446 related articles for article (PubMed ID: 3882831)
41. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
[TBL] [Abstract][Full Text] [Related]
42. Cell surface phenotype of a cloned line of human natural killer cells.
Kornbluth J; Flomenberg N; Dupont B
J Immunol; 1982 Dec; 129(6):2831-7. PubMed ID: 6982944
[TBL] [Abstract][Full Text] [Related]
43. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
[TBL] [Abstract][Full Text] [Related]
44. IFN-beta 2/IL-6 augments the activity of human natural killer cells.
Luger TA; Krutmann J; Kirnbauer R; Urbanski A; Schwarz T; Klappacher G; Köck A; Micksche M; Malejczyk J; Schauer E
J Immunol; 1989 Aug; 143(4):1206-9. PubMed ID: 2787359
[TBL] [Abstract][Full Text] [Related]
45. Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity.
Santoni A; Piccoli M; Ortaldo JR; Mason L; Wiltrout RH; Herberman RB
J Immunol; 1985 Apr; 134(4):2799-810. PubMed ID: 2579157
[TBL] [Abstract][Full Text] [Related]
46. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z
Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757
[TBL] [Abstract][Full Text] [Related]
47. Activation of rat and human alveolar macrophage intracellular microbicidal activity by a preformed LGL cytokine.
Gomez J; Pohajdak B; O'Neill S; Wilkins J; Greenberg AH
J Immunol; 1985 Aug; 135(2):1194-200. PubMed ID: 3925001
[TBL] [Abstract][Full Text] [Related]
48. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
[TBL] [Abstract][Full Text] [Related]
49. Lectin-dependent cell-mediated cytotoxicity and blastogenesis by large granular-enriched and depleted lymphocytes.
Perl A; Gonzalez-Cabello R; Laskay T; Benczur M; Láng I; Onódy K; Nékám K; Gergely P; Fehér J
Clin Exp Immunol; 1986 Jan; 63(1):171-8. PubMed ID: 3955881
[TBL] [Abstract][Full Text] [Related]
50. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N
J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745
[TBL] [Abstract][Full Text] [Related]
51. Selective phagocytosis of gram-positive bacteria and interleukin 1-like factor production by a subpopulation of large granular lymphocytes.
Abo T; Sugawara S; Amenomori A; Itoh H; Rikiishi H; Moro I; Kumagai K
J Immunol; 1986 May; 136(9):3189-97. PubMed ID: 3514754
[TBL] [Abstract][Full Text] [Related]
52. A short synthetic peptide fragment of human interleukin-1 beta increases both human and murine natural killer activity.
Peppoloni S; Bossù P; Boraschi D; Tagliabue A
Nat Immun Cell Growth Regul; 1989; 8(1):10-9. PubMed ID: 2785640
[TBL] [Abstract][Full Text] [Related]
53. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.
Ueno Y; Miyawaki T; Seki H; Matsuda A; Taga K; Sato H; Taniguchi N
J Immunol; 1985 Jul; 135(1):180-4. PubMed ID: 3923100
[TBL] [Abstract][Full Text] [Related]
54. Natural killer cell activity and autologous tumor killing activity in cancer patients: overlapping involvement of effector cells as determined in two-target conjugate cytotoxicity assay.
Uchida A; Yanagawa E
J Natl Cancer Inst; 1984 Nov; 73(5):1093-100. PubMed ID: 6593485
[TBL] [Abstract][Full Text] [Related]
55. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
[TBL] [Abstract][Full Text] [Related]
56. Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line.
Howell DN; Andreotti PE; Dawson JR; Cresswell P
J Immunol; 1985 Feb; 134(2):971-6. PubMed ID: 3871222
[TBL] [Abstract][Full Text] [Related]
57. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones.
Tsutsui H; Nakanishi K; Matsui K; Higashino K; Okamura H; Miyazawa Y; Kaneda K
J Immunol; 1996 Nov; 157(9):3967-73. PubMed ID: 8892629
[TBL] [Abstract][Full Text] [Related]
58. UV-irradiated epidermal cells produce a specific inhibitor of interleukin 1 activity.
Schwarz T; Urbanska A; Gschnait F; Luger TA
J Immunol; 1987 Mar; 138(5):1457-63. PubMed ID: 3492552
[TBL] [Abstract][Full Text] [Related]
59. Prostaglandin E2, monocyte adherence and interleukin-1 in the regulation of human natural killer cell activity by monocytes.
Bloom ET; Babbitt JT
Nat Immun Cell Growth Regul; 1990; 9(1):36-48. PubMed ID: 2139495
[TBL] [Abstract][Full Text] [Related]
60. Effect of cortisol on the native and in vitro induced non-MHC restricted cytotoxicity of large granular lymphocytes.
Matera L; Cardoso E; Veglia F; Cesano A; Bellone G; Vuolo A; Molinatti GM
J Clin Lab Immunol; 1988 Oct; 27(2):77-81. PubMed ID: 3266762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
